88 results on '"Rasigade JP"'
Search Results
2. PS-222 Staphylococcus Capitis In Neonatal Late-onset Sepsis: Unexpected Worldwide Dissemination Of An Endemic Multi-resistant Clone
- Author
-
Butin, M, primary, Martins Simoes, P, additional, Lemriss, H, additional, Lemriss, S, additional, Vandenesch, F, additional, Claris, O, additional, Picaud, JC, additional, Rasigade, JP, additional, and Laurent, F, additional
- Published
- 2014
- Full Text
- View/download PDF
3. Non-contiguous finished genome sequence of Staphylococcus capitis CR01 (pulsetype NRCS-A)
- Author
-
Lemriss, H., primary, Martins Simões, P, additional, Lemriss, S., additional, Butin, M., additional, Ibrahimi, A., additional, El Kabbaj, S., additional, Rasigade, JP, additional, and Laurent, F., additional
- Published
- 2014
- Full Text
- View/download PDF
4. Determinants of methicillin-susceptible Staphylococcus aureus native bone and joint infection treatment failure: a retrospective cohort study
- Author
-
Florent, Valour, Anissa, Bouaziz, Judith, Karsenty, Florence, Ader, Sébastien, Lustig, Frédéric, Laurent, Christian, Chidiac, Tristan, Ferry, Marion, Martinez, Lyon BJI study group, Ader, F., Biron, F., Boibieux, A., Bouaziz, A., Braun, E., Chidiac, C., Daoud, F., Ferry, T., Karsenty, J., Lippman, J., Miailhes, P., Perpoint, T., Peyramond, D., Vallat, MP., Valour, F., Barrey, C., Breton, P., Boucher, F., Desmarchelier, R., Fessy, MH., Guyen, O., Lienhart, C., Lustig, S., Mojallal, AA., Neyret, P., Trouillet, F., Vaz, G., Laurent, F., Rasigade, JP., Vandenesch, F., Deshayes, E., Giammarile, F., Janier, M., Morelec, I., Gagnieu, MC., Goutelle, S., Tod, M., and Martinez, M.
- Subjects
Adult ,Male ,Spondylodiscitis ,Staphylococcus aureus ,medicine.medical_specialty ,Bone and joint infection ,Arthritis ,Staphylococcal infections ,Methicillin ,Anti-Infective Agents ,Recurrence ,Interquartile range ,Internal medicine ,Odds Ratio ,medicine ,Humans ,Aged ,Anti-Bacterial Agents/therapeutic use ,Anti-Infective Agents/pharmacology ,Female ,Inflammation ,Logistic Models ,Methicillin/pharmacology ,Methicillin Resistance/drug effects ,Middle Aged ,Osteomyelitis/drug therapy ,Prognosis ,Retrospective Studies ,Staphylococcal Infections/drug therapy ,Staphylococcus aureus/drug effects ,Treatment Failure ,Treatment Outcome ,business.industry ,Osteomyelitis ,Retrospective cohort study ,Odds ratio ,Staphylococcal Infections ,medicine.disease ,Anti-Bacterial Agents ,Surgery ,Infectious Diseases ,Treatment failure ,Methicillin Resistance ,Methicillin Susceptible Staphylococcus Aureus ,business ,Research Article - Abstract
Background Although methicillin-susceptible Staphylococcus aureus (MSSA) native bone and joint infection (BJI) constitutes the more frequent clinical entity of BJI, prognostic studies mostly focused on methicillin-resistant S. aureus prosthetic joint infection. We aimed to assess the determinants of native MSSA BJI outcomes. Methods Retrospective cohort study (2001–2011) of patients admitted in a reference hospital centre for native MSSA BJI. Treatment failure determinants were assessed using Kaplan-Meier curves and binary logistic regression. Results Sixty-six patients (42 males [63.6%]; median age 61.2 years; interquartile range [IQR] 45.9–71.9) presented an acute (n = 38; 57.6%) or chronic (n = 28; 42.4%) native MSSA arthritis (n = 15; 22.7%), osteomyelitis (n = 19; 28.8%) or spondylodiscitis (n = 32; 48.5%), considered as “difficult-to-treat” in 61 cases (92.4%). All received a prolonged (27.1 weeks; IQR, 16.9–36.1) combined antimicrobial therapy, after surgical management in 37 cases (56.1%). Sixteen treatment failures (24.2%) were observed during a median follow-up period of 63.3 weeks (IQR, 44.7–103.1), including 13 persisting infections, 1 relapse after treatment disruption, and 2 super-infections. Independent determinants of treatment failure were the existence of a sinus tract (odds ratio [OR], 5.300; 95% confidence interval [CI], 1.166–24.103) and a prolonged delay to infectious disease specialist referral (OR, 1.134; 95% CI 1.013–1.271). Conclusions The important treatment failure rate pinpointed the difficulty of cure encountered in complicated native MSSA BJI. An early infectious disease specialist referral is essential, especially in debilitated patients or in presence of sinus tract. Electronic supplementary material The online version of this article (doi:10.1186/1471-2334-14-443) contains supplementary material, which is available to authorized users.
- Published
- 2014
5. Retrospective and prospective evaluation of the FluoroType®-Mycobacteria VER 1.0 assay for the identification of mycobacteria from cultures in a French center.
- Author
-
Piasecki L, Genestet C, Benito Y, Rasigade JP, Lina G, Dumitrescu O, and Hodille E
- Subjects
- Humans, Retrospective Studies, Prospective Studies, France, Bacterial Proteins genetics, Mycobacterium isolation & purification, Mycobacterium genetics, Mycobacterium classification, Polymerase Chain Reaction methods, Mycobacterium Infections, Nontuberculous microbiology, Mycobacterium Infections, Nontuberculous diagnosis, Chaperonin 60 genetics, Molecular Diagnostic Techniques methods, Sensitivity and Specificity, Nontuberculous Mycobacteria isolation & purification, Nontuberculous Mycobacteria classification, Nontuberculous Mycobacteria genetics
- Abstract
Purpose: Rapid, reliable identification of mycobacteria from positive cultures is essential for patient management, particularly for the differential diagnosis of Mycobacterium tuberculosis complex (MTBC) and nontuberculous mycobacteria (NTM) species. The aim of the present study was to evaluate a new "In-Vitro-Diagnostic"-certified PCR kit, FluoroType®-Mycobacteria VER 1.0 (Hain Lifescience GmbH) for NTM and MTBC identification from cultures., Methods: Mycobacteria identification isolated from positive cultures during routine practice at the Lyon university hospital mycobacteria laboratory obtained by hsp65 amplification/sequencing were compared retrospectively and prospectively to those obtained by and the FluoroType®-Mycobacteria VER 1.0 kit., Results: The overall agreement between hsp65 amplification/sequencing and the FluoroType®-Mycobacteria VER 1.0 kit was 88.4% (84/95); 91.2% (52/57) for the retrospective period and 84.2% (32/38) for the prospective period. There were 9 (9.5%) minor discrepancies (species in the FluoroType®-Mycobacteria VER 1.0 database and identified at genus level): 4 during the retrospective period, 5 during the prospective period; and 2 (2.1%) major discrepancies (species in the FluoroType®-Mycobacteria VER 1.0 database and identified incorrectly to species level): 1 during the retrospective period (M. kumamotonense identified as M. abscessus subsp massiliense by the kit) and 1 during the prospective period (M. chimaera identified as M. smegmatis by the kit). Including concordant results at genus level and minor discrepancies, 17.9% (17/95) of strains were identified as Mycobacterium sp. by the FluoroType®-Mycobacteria-VER 1.0 kit., Conclusion: The good performance of the FluoroType®-Mycobacteria-VER 1.0 kit with few major discrepancies could enable its use for first-line identification of positive mycobacteria cultures. However, an alternative identification method at least for reference laboratories is needed owing to the non-negligible proportion of NTM strains were identified at genus level., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
6. Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings.
- Author
-
Vacheron CH, Kaas A, Rasigade JP, Aubrun F, Argaud L, Balanca B, Fellahi JL, Richard JC, Lukaszewicz AC, Wallet F, Dauwalder O, and Friggeri A
- Published
- 2024
- Full Text
- View/download PDF
7. Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings.
- Author
-
Vacheron CH, Kaas A, Rasigade JP, Aubrun F, Argaud L, Balanca B, Fellahi JL, Richard JC, Lukaszewicz AC, Wallet F, Dauwalder O, and Friggeri A
- Abstract
Background: The efficacy and safety of cefiderocol in ICU patients with difficult-to-treat resistance (DTR) non-fermenting Gram-negative bacteria (Nf-GNB) are not as well-established. Consequently, we conducted a cohort study to compare Cefiderocol with the Best Available Therapy (BAT) in ICU patients., Methods: We included adult patients from 9 different ICUs, including a burn ICU unit, from 2019 to 2023 treated with Cefiderocol for DTR Nf-GNB isolated from the blood or lungs. We matched each patient at a 1:2 ratio based on the same DTR Nf-GBN isolated pathogen, and when possible, within the same type of ICU (burn unit or not). The primary endpoint of the study was the clinical cure at 15 days, with secondary endpoints including clinical cure at 30 days, relapse, and in-ICU mortality. For each outcome, adjusted odds ratios were estimated using bidirectional stepwise regression in a final model, which included 13 preselected confounders., Results: We included 27 patients with cefiderocol, matched with 54 patients receiving the BAT. Four patients were not exactly matched on the type of ICU unit. Characteristics were comparable between groups, mostly male with a Charlson Comorbidity Index of 3 [1-5], and 28% had immunosuppression. Cefiderocol patients were most likely to have higher number of antibiotic lines. The main DTR Nf-GNB identified was Pseudomonas aeruginosa (81.5%), followed by Acinetobater baumanii (14.8%) and Stenotrophomonas maltophilia (3.7%). Pneumonia was the identified infection in 21 (78.8%) patients in the Cefiderocol group and in 51 (94.4%) patients in the BAT group (p = 0.054). Clinical cure at 15 and 30-day and the in-ICU mortality was comparable between groups, however relapse was higher in the cefiderocol group (8-29.6% vs. 4-7.4%;aOR 10.06[1.96;51.53]) CONCLUSION: Cefiderocol did not show an improvement in clinical cure or mortality rates compared to BAT in the treatment of DTR Nf-GNB, but it was associated with a higher relapse rate., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
8. Rapid resistance detection is reliable for prompt adaptation of isoniazid resistant tuberculosis management.
- Author
-
Bahuaud O, Genestet C, Hodille E, Vallée M, Testard Q, Tataï C, Saison J, Rasigade JP, Lina G, Ader F, and Dumitrescu O
- Abstract
Objectives: Appropriate tuberculosis (TB) management requires anti-TB drugs resistance detection. We assessed the performance of rapid resistance detection assays and their impact on treatment adaptation, focusing on isoniazid resistant (Hr) TB., Methods: From 2016 to 2022, all TB cases enrolled in 3 hospitals were reviewed for phenotypic drug susceptibility testing (p-DST) and genotypic DST (g-DST) performed by rapid molecular testing, and next generation sequencing (NGS). Clinical characteristics, treatment and outcome were collected for Hr-TB patients. The concordance between g-DST and p-DST results, and delay between treatment initiation and results of g-DST and p-DST were respectively recorded to assess the contribution of DST results on Hr-TB management., Results: Among 654 TB cases enrolled, 29 were Hr-TB. Concordance between g-DST by rapid molecular methods and p-DST was 76.9 %, whilst concordance between NGS-based g-DST and p-DST was 98.7 %. Rapid resistance detection significantly fastened Hr-TB treatment adaptation (median delay between g-DST results and treatment modification was 6 days). It consisted in fluoroquinolone implementation for 17/23 patients; outcome was favourable except for 2 patients who died before DST reporting., Conclusion: Rapid resistance detection fastened treatment adaptation. Also, NGS-based g-DST showed almost perfect concordance with p-DST, thus providing rapid and safe culture-free DST alternative., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
9. Markers of epidemiological success of methicillin-resistant Staphylococcus aureus isolates in European populations.
- Author
-
Baede VO, Gupta A, Knight GM, Schouls LM, Laing K, Tavakol M, Barray A, de Vlas SJ, de Vos AS, Hendrickx APA, Khan M, Kretzschmar ME, van Wamel WJB, Lina G, Vandenesch F, Vos MC, Witney AA, Rasigade JP, and Lindsay JA
- Subjects
- Humans, Phylogeny, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Fluoroquinolones, Microbial Sensitivity Tests, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections microbiology
- Abstract
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) infections impose a considerable burden on health systems, yet there is remarkable variation in the global incidence and epidemiology of MRSA. The MACOTRA consortium aimed to identify bacterial markers of epidemic success of MRSA isolates in Europe using a representative MRSA collection originating from France, the Netherlands and the United Kingdom., Methods: Operational definitions of success were defined in consortium meetings to compose a balanced strain collection of successful and sporadic MRSA isolates. Isolates were subjected to antimicrobial susceptibility testing and whole-genome sequencing; genes were identified and phylogenetic trees constructed. Markers of epidemiological success were identified using genome-based time-scaled haplotypic density analysis and linear regression. Antimicrobial usage data from ESAC-Net was compared with national MRSA incidence data., Results: Heterogeneity of MRSA isolate collections across countries hampered the use of a unified operational definition of success; therefore, country-specific approaches were used to establish the MACOTRA strain collection. Phenotypic antimicrobial resistance varied within related MRSA populations and across countries. In time-scaled haplotypic density analysis, fluoroquinolone, macrolide and mupirocin resistance were associated with MRSA success, whereas gentamicin, rifampicin and trimethoprim resistance were associated with sporadicity. Usage of antimicrobials across 29 European countries varied substantially, and β-lactam, fluoroquinolone, macrolide and aminoglycoside use correlated with MRSA incidence., Discussion: Our results are the strongest yet to associate MRSA antibiotic resistance profiles and antibiotic usage with the incidence of infection and successful clonal spread, which varied by country. Harmonized isolate collection, typing, resistance profiling and alignment with antimicrobial usage over time will aid comparisons and further support country-specific interventions to reduce MRSA burden., (Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
10. The fitness cost of horizontally transferred and mutational antimicrobial resistance in Escherichia coli .
- Author
-
Vanacker M, Lenuzza N, and Rasigade JP
- Abstract
Antimicrobial resistance (AMR) in bacteria implies a tradeoff between the benefit of resistance under antimicrobial selection pressure and the incurred fitness cost in the absence of antimicrobials. The fitness cost of a resistance determinant is expected to depend on its genetic support, such as a chromosomal mutation or a plasmid acquisition, and on its impact on cell metabolism, such as an alteration in an essential metabolic pathway or the production of a new enzyme. To provide a global picture of the factors that influence AMR fitness cost, we conducted a systematic review and meta-analysis focused on a single species, Escherichia coli . By combining results from 46 high-quality studies in a multilevel meta-analysis framework, we find that the fitness cost of AMR is smaller when provided by horizontally transferable genes such as those encoding beta-lactamases, compared to mutations in core genes such as those involved in fluoroquinolone and rifampicin resistance. We observe that the accumulation of acquired AMR genes imposes a much smaller burden on the host cell than the accumulation of AMR mutations, and we provide quantitative estimates of the additional cost of a new gene or mutation. These findings highlight that gene acquisition is more efficient than the accumulation of mutations to evolve multidrug resistance, which can contribute to the observed dominance of horizontally transferred genes in the current AMR epidemic., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Vanacker, Lenuzza and Rasigade.)
- Published
- 2023
- Full Text
- View/download PDF
11. Targeted proteomics links virulence factor expression with clinical severity in staphylococcal pneumonia.
- Author
-
Pivard M, Bastien S, Macavei I, Mouton N, Rasigade JP, Couzon F, Youenou B, Tristan A, Carrière R, Moreau K, Lemoine J, and Vandenesch F
- Subjects
- Humans, Staphylococcus aureus, Virulence Factors genetics, Hemoptysis, Proteomics, Exotoxins genetics, Staphylococcus, Leukocidins genetics, Pneumonia, Staphylococcal microbiology, Staphylococcal Infections microbiology, Community-Acquired Infections microbiology, Methicillin-Resistant Staphylococcus aureus genetics
- Abstract
Introduction: The bacterial pathogen Staphylococcus aureus harbors numerous virulence factors that impact infection severity. Beyond virulence gene presence or absence, the expression level of virulence proteins is known to vary across S. aureus lineages and isolates. However, the impact of expression level on severity is poorly understood due to the lack of high-throughput quantification methods of virulence proteins., Methods: We present a targeted proteomic approach able to monitor 42 staphylococcal proteins in a single experiment. Using this approach, we compared the quantitative virulomes of 136 S. aureus isolates from a nationwide cohort of French patients with severe community-acquired staphylococcal pneumonia, all requiring intensive care. We used multivariable regression models adjusted for patient baseline health (Charlson comorbidity score) to identify the virulence factors whose in vitro expression level predicted pneumonia severity markers, namely leukopenia and hemoptysis, as well as patient survival., Results: We found that leukopenia was predicted by higher expression of HlgB, Nuc, and Tsst-1 and lower expression of BlaI and HlgC, while hemoptysis was predicted by higher expression of BlaZ and HlgB and lower expression of HlgC. Strikingly, mortality was independently predicted in a dose-dependent fashion by a single phage-encoded virulence factor, the Panton-Valentine leucocidin (PVL), both in logistic (OR 1.28; 95%CI[1.02;1.60]) and survival (HR 1.15; 95%CI[1.02;1.30]) regression models., Discussion: These findings demonstrate that the in vitro expression level of virulence factors can be correlated with infection severity using targeted proteomics, a method that may be adapted to other bacterial pathogens., Competing Interests: FV and JPR report research funding outside the scope of the present study by bioMérieux. FV reports two patents pending in antimicrobial resistance detection. FV, JL and J-PR report shares in Weezion. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be constructed as a potential conflict of interest., (Copyright © 2023 Pivard, Bastien, Macavei, Mouton, Rasigade, Couzon, Youenou, Tristan, Carrière, Moreau, Lemoine and Vandenesch.)
- Published
- 2023
- Full Text
- View/download PDF
12. Staphylococcus aureus Host Spectrum Correlates with Methicillin Resistance in a Multi-Species Ecosystem.
- Author
-
Ngoubangoye B, Fouchet D, Boundenga LA, Cassan C, Arnathau C, Meugnier H, Tsoumbou TA, Dibakou SE, Otsaghe Ekore D, Nguema YO, Moukodoum ND, Mabicka A, Ferry T, Rasigade JP, Prugnolle F, Bañuls AL, Renaud F, and Pontier D
- Abstract
Although antibiotic resistance is a major issue for both human and animal health, very few studies have investigated the role of the bacterial host spectrum in its dissemination within natural ecosystems. Here, we assessed the prevalence of methicillin resistance among Staphylococcus aureus (MRSA) isolates from humans, non-human primates (NHPs), micromammals and bats in a primatology center located in southeast Gabon, and evaluated the plausibility of four main predictions regarding the acquisition of antibiotic resistance in this ecosystem. MRSA strain prevalence was much higher in exposed species (i.e., humans and NHPs which receive antibiotic treatment) than in unexposed species (micromammals and bats), and in NHP species living in enclosures than those in captivity-supporting the assumption that antibiotic pressure is a risk factor in the acquisition of MRSA that is reinforced by the irregularity of drug treatment. In the two unexposed groups of species, resistance prevalence was high in the generalist strains that infect humans or NHPs, supporting the hypothesis that MRSA strains diffuse to wild species through interspecific transmission of a generalist strain. Strikingly, the generalist strains that were not found in humans showed a higher proportion of MRSA strains than specialist strains, suggesting that generalist strains present a greater potential for the acquisition of antibiotic resistance than specialist strains. The host spectrum is thus a major component of the issue of antibiotic resistance in ecosystems where humans apply strong antibiotic pressure.
- Published
- 2023
- Full Text
- View/download PDF
13. Matrix Assisted Laser Desorption Ionisation/Time Of Flight (MALDI/TOF) mass spectrometry is not done revolutionizing clinical microbiology diagnostic.
- Author
-
Dauwalder O, Cecchini T, Rasigade JP, and Vandenesch F
- Subjects
- Humans, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization methods, Lasers
- Published
- 2023
- Full Text
- View/download PDF
14. All Staphylococcus aureus bacteraemia-inducing strains can cause infective endocarditis: Results of GWAS and experimental animal studies.
- Author
-
Bastien S, Meyers S, Salgado-Pabón W, Giulieri SG, Rasigade JP, Liesenborghs L, Kinney KJ, Couzon F, Martins-Simoes P, Moing VL, Duval X, Holmes NE, Bruun NE, Skov R, Howden BP, Fowler VG Jr, Verhamme P, Andersen PS, Bouchiat C, Moreau K, and Vandenesch F
- Subjects
- Animals, Rabbits, Mice, Genome-Wide Association Study, Staphylococcus aureus genetics, Bacteremia microbiology, Staphylococcal Infections microbiology, Endocarditis, Bacterial microbiology, Endocarditis microbiology
- Abstract
Objectives: We aimed at determining whether specific S. aureus strains cause infective endocarditis (IE) in the course of Staphylococcus aureus bacteraemia (SAB)., Methods: A genome-wide association study (GWAS) including 924 S. aureus genomes from IE (274) and non-IE (650) SAB patients from international cohorts was conducted, and a subset of strains was tested with two experimental animal models of IE, one investigating the early step of bacterial adhesion to inflamed mice valves, the second evaluating the local and systemic developmental process of IE on mechanically-damaged rabbit valves., Results: The genetic profile of S. aureus IE and non-IE SAB strains did not differ when considering single nucleotide polymorphisms, coding sequences, and k-mers analysed in GWAS. In the murine inflammation-induced IE model, no difference was observed between IE and non-IE SAB strains both in terms of adhesion to the cardiac valves and in the propensity to cause IE; in the mechanical IE-induced rabbit model, there was no difference between IE and non-IE SAB strains regarding the vegetation size and CFU., Conclusion: All strains of S. aureus isolated from SAB patients must be considered as capable of causing this common and lethal infection once they have accessed the bloodstream., Competing Interests: Declaration of Competing Interest FV reports research funding outside the scope of the present study by bioMérieux, two patents pending in antimicrobial resistance detection and shares in Weezion. VGF reports personal fees from Novartis, Novadigm, Durata, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., Cerexa, Tetraphase, Trius, MedImmune, Bayer, Theravance, Basilea, Affinergy, Janssen, xBiotech, Contrafect, Regeneron, Basilea, Destiny, Amphliphi Biosciences. Integrated Biotherapeutics; C3J, grants from NIH, MedImmune, Cerexa/Forest/Actavis/Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Cubist/Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius; Genentech, Regeneron, Basilea, Janssen, from Green Cross, Cubist, Cerexa, Durata, Theravance; Debiopharm, Royalties from UpToDate; and a patent pending in sepsis diagnostics., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
15. Nasal microbiome disruption and recovery after mupirocin treatment in Staphylococcus aureus carriers and noncarriers.
- Author
-
Baede VO, Barray A, Tavakol M, Lina G, Vos MC, and Rasigade JP
- Subjects
- Humans, Mupirocin pharmacology, Mupirocin therapeutic use, Staphylococcus aureus, Chlorhexidine pharmacology, Prospective Studies, Cohort Studies, Carrier State drug therapy, Carrier State microbiology, Staphylococcal Infections drug therapy, Staphylococcal Infections microbiology, Microbiota genetics
- Abstract
Nasal decolonization procedures against the opportunistic pathogen Staphylococcus aureus rely on topical antimicrobial drug usage, whose impact on the nasal microbiota is poorly understood. We examined this impact in healthy S. aureus carriers and noncarriers. This is a prospective interventional cohort study of 8 S. aureus carriers and 8 noncarriers treated with nasal mupirocin and chlorhexidine baths. Sequential nasal swabs were taken over 6 months. S. aureus was detected by quantitative culture and genotyped using spa typing. RNA-based 16S species-level metabarcoding was used to assess the living microbial diversity. The species Dolosigranulum pigrum, Moraxella nonliquefaciens and Corynebacterium propinquum correlated negatively with S. aureus carriage. Mupirocin treatment effectively eliminated S. aureus, D. pigrum and M. nonliquefaciens, but not corynebacteria. S. aureus recolonization in carriers occurred more rapidly than recolonization by the dominant species in noncarriers (median 3 vs. 6 months, respectively). Most recolonizing S. aureus isolates had the same spa type as the initial isolate. The impact of mupirocin-chlorhexidine treatment on the nasal microbiota was still detectable after 6 months. S. aureus recolonization predated microbiota recovery, emphasizing the strong adaptation of this pathogen to the nasal niche and the transient efficacy of the decolonization procedure., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
16. Transcontinental spread and evolution of Mycobacterium tuberculosis W148 European/Russian clade toward extensively drug resistant tuberculosis.
- Author
-
Merker M, Rasigade JP, Barbier M, Cox H, Feuerriegel S, Kohl TA, Shitikov E, Klaos K, Gaudin C, Antoine R, Diel R, Borrell S, Gagneux S, Nikolayevskyy V, Andres S, Crudu V, Supply P, Niemann S, and Wirth T
- Subjects
- Antitubercular Agents pharmacology, Antitubercular Agents therapeutic use, Bayes Theorem, Drug Resistance, Multiple, Bacterial genetics, Humans, Microbial Sensitivity Tests, Extensively Drug-Resistant Tuberculosis drug therapy, Extensively Drug-Resistant Tuberculosis epidemiology, Extensively Drug-Resistant Tuberculosis microbiology, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant drug therapy, Tuberculosis, Multidrug-Resistant epidemiology, Tuberculosis, Multidrug-Resistant microbiology
- Abstract
Transmission-driven multi-/extensively drug resistant (M/XDR) tuberculosis (TB) is the largest single contributor to human mortality due to antimicrobial resistance. A few major clades of the Mycobacterium tuberculosis complex belonging to lineage 2, responsible for high prevalence of MDR-TB in Eurasia, show outstanding transnational distributions. Here, we determined factors underlying the emergence and epidemic spread of the W148 clade by genome sequencing and Bayesian demogenetic analyses of 720 isolates from 23 countries. We dated a common ancestor around 1963 and identified two successive epidemic expansions in the late 1980s and late 1990s, coinciding with major socio-economic changes in the post-Soviet Era. These population expansions favored accumulation of resistance mutations to up to 11 anti-TB drugs, with MDR evolving toward additional resistances to fluoroquinolones and second-line injectable drugs within 20 years on average. Timescaled haplotypic density analysis revealed that widespread acquisition of compensatory mutations was associated with transmission success of XDR strains. Virtually all W148 strains harbored a hypervirulence-associated ppe38 gene locus, and incipient recurrent emergence of prpR mutation-mediated drug tolerance was detected. The outstanding genetic arsenal of this geographically widespread M/XDR strain clade represents a "perfect storm" that jeopardizes the successful introduction of new anti-M/XDR-TB antibiotic regimens., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
17. High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region.
- Author
-
Dreyer V, Mandal A, Dev P, Merker M, Barilar I, Utpatel C, Nilgiriwala K, Rodrigues C, Crook DW, Rasigade JP, Wirth T, Mistry N, and Niemann S
- Subjects
- Antitubercular Agents pharmacology, Antitubercular Agents therapeutic use, Clone Cells, Drug Resistance, Multiple, Bacterial genetics, Fluoroquinolones pharmacology, Fluoroquinolones therapeutic use, Humans, Microbial Sensitivity Tests, Multilocus Sequence Typing, Retrospective Studies, Extensively Drug-Resistant Tuberculosis drug therapy, Extensively Drug-Resistant Tuberculosis epidemiology, Extensively Drug-Resistant Tuberculosis microbiology, Mycobacterium tuberculosis genetics, Tuberculosis, Multidrug-Resistant drug therapy, Tuberculosis, Multidrug-Resistant epidemiology, Tuberculosis, Multidrug-Resistant microbiology
- Abstract
Background: Multidrug-resistant (MDR) Mycobacterium tuberculosis complex (MTBC) strains are a serious health problem in India, also contributing to one-fourth of the global MDR tuberculosis (TB) burden. About 36% of the MDR MTBC strains are reported fluoroquinolone (FQ) resistant leading to high pre-extensively drug-resistant (pre-XDR) and XDR-TB (further resistance against bedaquiline and/or linezolid) rates. Still, factors driving the MDR/pre-XDR epidemic in India are not well defined., Methods: In a retrospective study, we analyzed 1852 consecutive MTBC strains obtained from patients from a tertiary care hospital laboratory in Mumbai by whole genome sequencing (WGS). Univariate and multivariate statistics was used to investigate factors associated with pre-XDR. Core genome multi locus sequence typing, time scaled haplotypic density (THD) method and homoplasy analysis were used to analyze epidemiological success, and positive selection in different strain groups, respectively., Results: In total, 1016 MTBC strains were MDR, out of which 703 (69.2%) were pre-XDR and 45 (4.4%) were XDR. Cluster rates were high among MDR (57.8%) and pre-XDR/XDR (79%) strains with three dominant L2 (Beijing) strain clusters (Cl 1-3) representing half of the pre-XDR and 40% of the XDR-TB cases. L2 strains were associated with pre-XDR/XDR-TB (P < 0.001) and, particularly Cl 1-3 strains, had high first-line and FQ resistance rates (81.6-90.6%). Epidemic success analysis using THD showed that L2 strains outperformed L1, L3, and L4 strains in short- and long-term time scales. More importantly, L2 MDR and MDR + strains had higher THD success indices than their not-MDR counterparts. Overall, compensatory mutation rates were highest in L2 strains and positive selection was detected in genes of L2 strains associated with drug tolerance (prpB and ppsA) and virulence (Rv2828c). Compensatory mutations in L2 strains were associated with a threefold increase of THD indices, suggesting improved transmissibility., Conclusions: Our data indicate a drastic increase of FQ resistance, as well as emerging bedaquiline resistance which endangers the success of newly endorsed MDR-TB treatment regimens. Rapid changes in treatment and control strategies are required to contain transmission of highly successful pre-XDR L2 strains in the Mumbai Metropolitan region but presumably also India-wide., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
18. Heterogeneous vancomycin resistance in Staphylococcus aureus does not predict development of vancomycin resistance upon vancomycin pressure.
- Author
-
Gaillard T, Dupieux-Chabert C, Butin M, Dumitrescu O, Naceur O, Bouveyron C, Martra A, Bes M, Tristan A, Vandenesch F, Lina G, Laurent F, and Rasigade JP
- Subjects
- Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Humans, Microbial Sensitivity Tests, Staphylococcus aureus, Vancomycin pharmacology, Vancomycin Resistance, Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections drug therapy
- Abstract
Background: It is unclear whether Staphylococcus aureus with heterogeneous intermediate vancomycin resistance (hVISA) can develop vancomycin resistance faster than vancomycin-susceptible S. aureus (VSSA) strains., Methods: We compared the kinetics of vancomycin MIC increase for 15 days of sustained in vitro vancomycin exposure for clinical hVISA (n = 12) and VSSA (n = 24) isolates, as well as for reference strains Mu3 (hVISA) and ATCC 29213 (VSSA). Clinical isolates were categorized as hVISA using the population analysis profile method. MICs were monitored for 15 days and the rate of MIC increase under exposure, for each strain, was evaluated in a linear regression model relative to time., Results: All isolates acquired vancomycin resistance upon exposure. Vancomycin MICs increased faster for VSSA compared with hVISA isolates (P < 0.01)., Conclusions: The hVISA phenotype does not correspond to an enhanced adaptation potential to in vitro vancomycin pressure., (© The Author(s) 2022. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2022
- Full Text
- View/download PDF
19. Prognostic factors of severe community-acquired staphylococcal pneumonia in France.
- Author
-
Gillet Y, Tristan A, Rasigade JP, Saadatian-Elahi M, Bouchiat C, Bes M, Dumitrescu O, Leloire M, Dupieux C, Laurent F, Lina G, Etienne J, Vanhems P, Argaud L, and Vandenesch F
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Cohort Studies, Exotoxins, France epidemiology, Humans, Infant, Infant, Newborn, Leukocidins genetics, Middle Aged, Prognosis, Prospective Studies, Staphylococcus aureus, Young Adult, Community-Acquired Infections epidemiology, Methicillin-Resistant Staphylococcus aureus, Pneumonia, Staphylococcal epidemiology
- Abstract
Purpose: Staphylococcus aureus causes severe forms of community-acquired pneumonia (CAP), namely staphylococcal pleuropneumonia in young children and staphylococcal necrotising pneumonia in older patients. Methicillin resistance and the Panton-Valentine leukocidin (PVL) toxin, as well as less specific factors, have been associated with poor outcome in severe CAP, but their roles are unclear., Methods: A prospective multicentre cohort study of severe staphylococcal CAP was conducted in 77 paediatric and adult intensive care units in France between January 2011 and December 2016. After age-clustering, risk factors for mortality, including pre-existing conditions, clinical presentation, laboratory features, strain genetic lineage, PVL, other virulence factors and methicillin resistance were assessed using univariate and multivariable Cox and LASSO (least absolute shrinkage and selection operator) regressions., Results: Out of 163 included patients, aged 1 month to 87 years, 85 (52.1%) had PVL-positive CAP; there were 20 (12.3%) patients aged <3 years (hereafter "toddlers"), among whom 19 (95%) had PVL-positive CAP. The features of PVL-positive CAP in toddlers matched with the historical description of staphylococcal pleuropneumonia, with a lower mortality (three (15%) out of 19) compared to PVL-positive CAP in older patients (31 (47%) out of 66). Mortality in older patients was predicted by PVL-positivity (hazard ratio (HR) 1.81, 95% CI 1.03-3.17) and methicillin resistance (HR 2.37, 95% CI 1.29-4.34) independently from S. aureus lineages and the presence of other determinants of virulence., Conclusion: PVL was associated with staphylococcal pleuropneumonia in toddlers and was a risk factor for mortality in older patients with severe CAP, independently of methicillin resistance, S. aureus genetic background and other virulence factors., Competing Interests: Conflict of interest: Y. Gillet has nothing to disclose. Conflict of interest: A. Tristan has nothing to disclose. Conflict of interest: J-P. Rasigade reports personal fees from MSD and Pfizer, grants from bioMérieux, outside the submitted work. Conflict of interest: M. Saadatian-Elahi has nothing to disclose. Conflict of interest: C. Bouchiat has nothing to disclose. Conflict of interest: M. Bès has nothing to disclose. Conflict of interest: O. Dumitrescu has nothing to disclose. Conflict of interest: M. Leloire has nothing to disclose. Conflict of interest: C. Dupieux has nothing to disclose. Conflict of interest: F. Laurent has nothing to disclose. Conflict of interest: G. Lina has nothing to disclose. Conflict of interest: J. Etienne has nothing to disclose. Conflict of interest: P. Vanhems reports personal fees from Astellas, Biosciences and Pfizer, grants from Anios and MSD, outside the submitted work. Conflict of interest: L. Argaud has nothing to disclose. Conflict of interest: F. Vandenesch has nothing to disclose., (Copyright ©The authors 2021.)
- Published
- 2021
- Full Text
- View/download PDF
20. Trends in bacterial bloodstream infections and resistance in immuno-compromised patients with febrile neutropenia: a retrospective analysis.
- Author
-
Raad C, Behdenna A, Fuhrmann C, Conter C, Cuzzubbo D, Rasigade JP, Bertrand Y, and Domenech C
- Subjects
- Anti-Bacterial Agents therapeutic use, Bacteria, Child, Humans, Retrospective Studies, Bacteremia epidemiology, Bacterial Infections, Febrile Neutropenia drug therapy, Febrile Neutropenia epidemiology, Sepsis
- Abstract
Bacterial infections remain a major cause of morbidity and mortality in immunocompromised children. From the onset of fever, an early administration of broad-spectrum antibiotics is begun; this strategy could induce emergence of multi-drug resistant bacteria (MDR). We describe the incidence and microbiological spectrum, including MDR bacteria of bacterial documented blood-stream infections (BSI) in immunocompromised children. A retrospective, descriptive study was conducted in a tertiary referral centre in France from January 2014 to December 2017. Our cohort included a large scale of patients with febrile neutropenia: haematological and oncological malignancies, haematopoietic stem cell transplantations, severe combined immunodeficiency syndromes. BSI were defined by positive blood culture samples associated with fever. Among 760 febrile neutropenia episodes in 7301 admitted patients, we identified 310 documented BSI with a mean of 7.4 BSI/1000 patient bed days. Only 2.9% BSIs were caused by MDR bacteria, none vancomycin resistant. Coagulase-negative staphylococci were identified in 49.7% BSI and Staphylococcus aureus caused 6.5% infections. Gram-negative bacilli accounted for 21.6% of isolated bacteria, Pseudomonas for 4.8%. The incidence of BSI annually decreased by 0.75% (p = 0.002).Conclusion: With a step-down strategy at 48 h of initial broad-spectrum antibiotic therapy, we reported a low number of MDR bacteria, no deaths related to BSI. What is Known: • Bacterial bloodstream infections are a leading cause of morbidity and mortality in immunocompromised children • Multi-drug resistant bacteria are emerging worldwide. What is New: • Initial broad-spectrum antibiotic therapy with a step-down strategy at 48 h: no deaths related to bloodstream infections with a low number of resistant bacteria. • Parental and nurse stewardship to decrease bloodstream infections incidence with a drop of staphylococcal infections., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
21. Automated surveillance in French ICUs: is it feasible? Results from a survey in French ICUs participating in a surveillance network.
- Author
-
Lepape A, Machut A, Gerbier-Colomban S, Kuczewski E, Rasigade JP, Timsit JF, Vanhems P, Wallet F, Savey A, and Friggeri A
- Subjects
- Anti-Bacterial Agents therapeutic use, Humans, Intensive Care Units, Prohibitins, Surveys and Questionnaires, Anti-Infective Agents, Cross Infection drug therapy, Cross Infection epidemiology, Cross Infection prevention & control
- Abstract
A survey was undertaken to evaluate the level of computerization in intensive care units (ICUs) within a French network dedicated to the surveillance of healthcare-associated infections, antimicrobial use (AMU) and antimicrobial resistance (AMR) in ICUs (REA-REZO). Ninety-eight ICUs responded, and patient records were computerized in 57%, antimicrobial prescriptions were computerized in 59% and AMR epidemiology was computerized in 72%. AMU and AMR feedback was provided to the ICU itself for 77% and 65% of ICUs, respectively, and feedback was provided to the national surveillance for 79% and 65% of ICUs, respectively. This study suggests that the level of computerization in ICUs requires further improvement., (Copyright © 2021 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
22. The MTB/MDR ELITe MGB ® Kit: Performance Assessment for Pulmonary, Extra-Pulmonary, and Resistant Tuberculosis Diagnosis, and Integration in the Laboratory Workflow of a French Center.
- Author
-
Hodille E, Genestet C, Delque T, Ruffel L, Benito Y, Fredenucci I, Rasigade JP, Lina G, and Dumitrescu O
- Abstract
A rapid and reliable diagnostic for tuberculosis, including the detection of both rifampicin (RIF) and isoniazid (INH) resistance, is essential for appropriate patient care. Nucleic acid amplification tests are a fast alternative to methods based on Mycobacterium tuberculosis complex (MTB) cultures. Thus, the performance of the MDR/MTB ELITe MGB
® Kit on the ELITe InGenius® platform was retrospectively evaluated for MTB detection on pulmonary and extra-pulmonary samples and for RIF/INH resistance detection on MTB strains. The sensitivity and specificity of the kit for MTB detection compared to the MTB culture were 80.0% and 100.0%, respectively. For the antimicrobial susceptibility prediction, the agreement with phenotypic antimicrobial susceptibility testing (AST) was 92.0%. For RIF, the sensitivity was 100.0% and the specificity was 95.5%. For INH, the sensitivity and specificity were 75.0% and 100.0%, respectively. A single RIF false-positive result was obtained for a strain with a low level of RIF resistance that was not detected by phenotypic AST, but carrying a rpoB L452P mutation. INH false-negative results (3) were due to mutations on the katG gene that were not probed by the test. Overall, the MTB/MDR ELITe MGB® Kit presents a strong performance for MTB detection and for the detection of both RIF and INH resistance, with an easy integration in laboratory workflow thanks to its fully automatized system.- Published
- 2021
- Full Text
- View/download PDF
23. Metapopulation ecology links antibiotic resistance, consumption, and patient transfers in a network of hospital wards.
- Author
-
Shapiro JT, Leboucher G, Myard-Dury AF, Girardo P, Luzzati A, Mary M, Sauzon JF, Lafay B, Dauwalder O, Laurent F, Lina G, Chidiac C, Couray-Targe S, Vandenesch F, Flandrois JP, and Rasigade JP
- Subjects
- Bacterial Infections drug therapy, Humans, Patient Transfer, Sepsis drug therapy, Sepsis microbiology, Anti-Bacterial Agents pharmacology, Bacteria drug effects, Bacterial Infections microbiology, Cross Infection microbiology, Drug Resistance, Bacterial, Hospitals
- Abstract
Antimicrobial resistance (AMR) is a global threat. A better understanding of how antibiotic use and between-ward patient transfers (or connectivity) impact population-level AMR in hospital networks can help optimize antibiotic stewardship and infection control strategies. Here, we used a metapopulation framework to explain variations in the incidence of infections caused by seven major bacterial species and their drug-resistant variants in a network of 357 hospital wards. We found that ward-level antibiotic consumption volume had a stronger influence on the incidence of the more resistant pathogens, while connectivity had the most influence on hospital-endemic species and carbapenem-resistant pathogens. Piperacillin-tazobactam consumption was the strongest predictor of the cumulative incidence of infections resistant to empirical sepsis therapy. Our data provide evidence that both antibiotic use and connectivity measurably influence hospital AMR. Finally, we provide a ranking of key antibiotics by their estimated population-level impact on AMR that might help inform antimicrobial stewardship strategies., Competing Interests: JS, GL, AM, PG, AL, MM, JS, BL, OD, FL, GL, CC, SC, FV, JF, JR No competing interests declared, (© 2020, Shapiro et al.)
- Published
- 2020
- Full Text
- View/download PDF
24. Applied phyloepidemiology: Detecting drivers of pathogen transmission from genomic signatures using density measures.
- Author
-
Wirth T, Wong V, Vandenesch F, and Rasigade JP
- Abstract
Understanding the driving forces of an epidemic is key to inform intervention strategies against it. Correlating measures of the epidemic success of a pathogen with ancillary parameters such as its drug resistance profile provides a flexible tool to identify such driving forces. The recently described time-scaled haplotypic density (THD) method facilitates the inference of a pathogen's epidemic success from genetic data. Contrary to demogenetic approaches that define success in an aggregated fashion, the THD computes an independent index of success for each isolate in a collection. Modeling this index using multivariate regression, thus, allows us to control for various sources of bias and to identify independent predictors of success. We illustrate the use of THD to address key questions regarding three exemplary epidemics of multidrug-resistant (MDR) bacterial lineages, namely Mycobacterium tuberculosis Beijing, Salmonella Typhi H58, and Staphylococcus aureus ST8 (including ST8-USA300 MRSA), based on previously published, international genetic datasets. In each case, THD analysis allowed to identify the impact, or lack thereof, of various factors on the epidemic success, independent of confounding by population structure and geographic distribution. Our results suggest that rifampicin resistance drives the MDR Beijing epidemic and that fluoroquinolone resistance drives the S. aureus ST8/USA300 epidemic, in line with previous evidence of a lack of resistance-associated fitness cost in these pathogens. Conversely, fluoroquinolone resistance measurably hampered the success of S. Typhi H58 and non-H58. These findings illustrate how THD can help leverage the massive genomic datasets generated by molecular epidemiology studies to address new questions. THD implementation for the R platform is available at https://github.com/rasigadelab/thd., Competing Interests: None declared., (© 2020 The Authors. Evolutionary Applications published by John Wiley & Sons Ltd.)
- Published
- 2020
- Full Text
- View/download PDF
25. Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis.
- Author
-
Wirth T, Bergot M, Rasigade JP, Pichon B, Barbier M, Martins-Simoes P, Jacob L, Pike R, Tissieres P, Picaud JC, Kearns A, Supply P, Butin M, and Laurent F
- Subjects
- Adult, Bayes Theorem, France, Genes, Bacterial genetics, Genome, Bacterial, Genome-Wide Association Study, Genotype, Humans, Infant, Infant, Newborn, Intensive Care Units, Neonatal, Microbial Sensitivity Tests, Mutation, Phenotype, Polymorphism, Single Nucleotide, Recombination, Genetic, Staphylococcal Infections microbiology, Staphylococcus capitis isolation & purification, Staphylococcus capitis pathogenicity, Vancomycin therapeutic use, Anti-Bacterial Agents pharmacology, Drug Resistance, Multiple, Bacterial drug effects, Drug Resistance, Multiple, Bacterial genetics, Neonatal Sepsis microbiology, Staphylococcus capitis drug effects, Staphylococcus capitis genetics
- Abstract
The multidrug-resistant Staphylococcus capitis NRCS-A clone is responsible for sepsis in preterm infants in neonatal intensive care units (NICUs) worldwide. Here, to retrace the spread of this clone and to identify drivers of its specific success, we investigated a representative collection of 250 S. capitis isolates from adults and newborns. Bayesian analyses confirmed the spread of the NRCS-A clone and enabled us to date its emergence in the late 1960s and its expansion during the 1980s, coinciding with the establishment of NICUs and the increasing use of vancomycin in these units, respectively. This dynamic was accompanied by the acquisition of mutations in antimicrobial resistance- and bacteriocin-encoding genes. Furthermore, combined statistical tools and a genome-wide association study convergently point to vancomycin resistance as a major driver of NRCS-A success. We also identified another S. capitis subclade (alpha clade) that emerged independently, showing parallel evolution towards NICU specialization and non-susceptibility to vancomycin, indicating convergent evolution in NICU-associated pathogens. These findings illustrate how the broad use of antibiotics can repeatedly lead initially commensal drug-susceptible bacteria to evolve into multidrug-resistant clones that are able to successfully spread worldwide and become pathogenic for highly vulnerable patients.
- Published
- 2020
- Full Text
- View/download PDF
26. Routine survey of Mycobacterium tuberculosis isolates reveals nosocomial transmission.
- Author
-
Genestet C, Paret R, Pichat C, Berland JL, Jacomo V, Carret G, Fredenucci I, Hodille E, Rasigade JP, Boisset S, Carricajo A, Lina G, Ronnaux-Baron AS, Mornex JF, Grando J, Sénéchal A, Ader F, and Dumitrescu O
- Subjects
- Antitubercular Agents, Genotype, Humans, Cross Infection, Mycobacterium tuberculosis, Tuberculosis, Pulmonary
- Abstract
Competing Interests: Sequences have been submitted to European Nucleotide Archive (ENA) under accession number PRJEB33569. Conflict of interest: C. Genestet reports grants from LABEX ECOFECT (ANR-11-LABX-0048) of Lyon University, within the program “Investissements d'Avenir” (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR), during the conduct of the study. Conflict of interest: R. Paret has nothing to disclose. Conflict of interest: C. Pichat has nothing to disclose. Conflict of interest: J-L. Berland has nothing to disclose. Conflict of interest: V. Jacomo has nothing to disclose. Conflict of interest: G. Carret has nothing to disclose. Conflict of interest: I. Fredenucci has nothing to disclose. Conflict of interest: E. Hodille has nothing to disclose. Conflict of interest: J-P. Rasigade has nothing to disclose. Conflict of interest: S. Boisset has nothing to disclose. Conflict of interest: A. Carricajo has nothing to disclose. Conflict of interest: G. Lina has nothing to disclose. Conflict of interest: A-S. Ronnaux-Baron has nothing to disclose. Conflict of interest: J-F. Mornex has nothing to disclose. Conflict of interest: J. Grando has nothing to disclose. Conflict of interest: A. Sénéchal has nothing to disclose. Conflict of interest: F. Ader has nothing to disclose. Conflict of interest: O. Dumitrescu has nothing to disclose.
- Published
- 2020
- Full Text
- View/download PDF
27. Author Correction: Complex ecological interactions of Staphylococcus aureus in tampons during menstruation.
- Author
-
Jacquemond I, Muggeo A, Lamblin G, Tristan A, Gillet Y, Bolze PA, Bes M, Gustave CA, Rasigade JP, Golfier F, Ferry T, Dubost A, Abrouk D, Barreto S, Prigent-Combaret C, Thioulouse J, Lina G, and Muller D
- Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Published
- 2020
- Full Text
- View/download PDF
28. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
- Author
-
Hodille E, Maisson A, Charlet L, Bauduin C, Genestet C, Fredenucci I, Rasigade JP, Lina G, and Dumitrescu O
- Subjects
- Antibiotics, Antitubercular pharmacology, Diagnostic Tests, Routine, Drug Resistance, Bacterial drug effects, Drug Resistance, Bacterial genetics, Humans, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis genetics, Retrospective Studies, Rifampin pharmacology, Sensitivity and Specificity, Tuberculosis, Multidrug-Resistant diagnosis, Tuberculosis, Multidrug-Resistant microbiology, Tuberculosis, Pulmonary microbiology, Molecular Diagnostic Techniques methods, Mycobacterium tuberculosis physiology, Sputum microbiology, Tuberculosis, Pulmonary diagnosis
- Abstract
Tuberculosis (TB) is a worldwide public health concern, including in high-resource countries with a low prevalence of TB. Xpert MTB/RIF assay was developed to improve TB and rifampicin (RIF) resistance detection, but sensitivity remains poor on smear-negative sputum. Xpert MTB/RIF Ultra assay was designed to enhance the sensitivity of TB detection in clinical samples. Herein, we evaluated retrospectively the performance of this test on smear-negative respiratory samples. Respiratory specimens with smear-negative and a Mycobacterium tuberculosis (MTB) complex-positive culture were retrospectively selected from those taken from patients during routine care, and analysed in the Mycobacteria Laboratory of the Lyon University hospital, France. Specimens were stored at - 20 °C before testing by Xpert MTB/RIF Ultra. For each sample, growth delay and date of anti-TB treatment initiation were recorded. Forty-six samples-29 sputum, 8 bronchial aspirates, 6 broncho-alveolar lavages, and 3 gastric aspirates-were selected. Among samples collected before treatment initiation (n = 33), sensitivity was 81.8% (95% CI [64.5; 93.0]) and there was a significant correlation between the quantitative measurements (Ct) of Xpert MTB/RIF Ultra assay and the time to growth detection in culture. Among samples collected after treatment initiation (n = 12), sensitivity was 100%, without correlation with time to growth detection due to presence of afterglow DNA in samples. In high-resource settings, the Xpert MTB/RIF Ultra test represents a useful tool for pulmonary TB diagnosis, notably for the paucibacillary forms. Moreover, quantitative measurement of Xpert MTB/RIF Ultra could help to predict time to MTB culture positivity and be used as a quality indicator of MTB culture process.
- Published
- 2019
- Full Text
- View/download PDF
29. Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018.
- Author
-
Genestet C, Tatai C, Berland JL, Claude JB, Westeel E, Hodille E, Fredenucci I, Rasigade JP, Ponsoda M, Jacomo V, Vachée A, Gaudart A, Gaillard JL, Roux AL, Ader F, Tararbit K, Terpant G, Bryant JE, Lina G, and Dumitrescu O
- Subjects
- France epidemiology, History, 21st Century, Humans, Mycobacterium tuberculosis classification, Polymorphism, Single Nucleotide, Population Surveillance, Tuberculosis history, Disease Outbreaks, Genome, Bacterial, Mycobacterium tuberculosis genetics, Tuberculosis epidemiology, Tuberculosis microbiology, Whole Genome Sequencing
- Abstract
During June 2017-April 2018, active tuberculosis with Beijing SIT1 isolates was diagnosed in 14 persons living in 4 distant cities in France. Whole-genome sequencing indicated that these patients belonged to a single transmission chain. Whole-genome sequencing-based laboratory investigations enabled prompt tracing of linked cases to improve tuberculosis control.
- Published
- 2019
- Full Text
- View/download PDF
30. Microorganisms associated with respiratory syncytial virus pneumonia in the adult population.
- Author
-
Jeannoël M, Lina G, Rasigade JP, Lina B, Morfin F, and Casalegno JS
- Subjects
- Adolescent, Adult, Aged, Bacteria isolation & purification, Coinfection complications, Coinfection epidemiology, Coinfection microbiology, Coinfection virology, Female, Humans, Male, Middle Aged, Pneumonia, Bacterial complications, Pneumonia, Bacterial epidemiology, Pneumonia, Bacterial virology, Pneumonia, Viral complications, Pneumonia, Viral epidemiology, Pneumonia, Viral virology, Respiratory Syncytial Virus Infections complications, Respiratory Syncytial Virus Infections epidemiology, Respiratory Syncytial Virus Infections virology, Respiratory Syncytial Virus, Human, Retrospective Studies, Superinfection complications, Superinfection epidemiology, Superinfection virology, Young Adult, Pneumonia, Bacterial microbiology, Pneumonia, Viral microbiology, Respiratory Syncytial Virus Infections microbiology, Superinfection microbiology
- Abstract
Respiratory syncytial virus (RSV) has been recognized as responsible for severe respiratory illness in adults, especially in the elderly. While pneumonia is commonly observed during RSV infection, the burden and epidemiology of bacterial superinfection is poorly understood. The aim of this study was to identify microorganisms associated with RSV-positive pneumonia in adults. A retrospective study was conducted during three consecutive winters (October to April 2013-2016) in the University Hospital of Lyon, France. During RSV circulation periods, a systematic RSV screening was performed by reverse-transcription PCR on all respiratory samples collected from adults. Records of RSV-positive patients were subsequently analyzed to identify radiologically confirmed pneumonia cases. Bacteria were identified by standard bacteriology cultures or urinary antigen screening and classified as potentially causative of pneumonia if quantification was above the specific threshold as defined by the European Manual of Clinical Microbiology. Overall, 14,792 adult respiratory samples were screened for RSV detection by PCR. In total, 292 had a positive RSV detection (2.0%) among which 89 presented with pneumonia including 27 bacterial superinfections (9.3%) with Streptococcus pneumonia, Haemophilus influenza, Staphylococcus aureus, Pseudomonas aeruginosa, and Moraxella catarrhalis. Most patients were elderly (55.6%) and patients with comorbidities (77.8%). A more severe outcome was observed for RSV-bacteria-associated pneumonia compared with RSV pneumonia: length of stay was significantly longer (16 days vs 10 days) and ICU hospitalization more frequent (66.7% vs 21.0%) (p < 0.05). In conclusion, we did not observe major differences in the epidemiology of bacterial superinfections in RSV-positive pneumonia compared to reports on post-influenza pneumonia.
- Published
- 2019
- Full Text
- View/download PDF
31. Genes under positive selection in the core genome of pathogenic Bacillus cereus group members.
- Author
-
Rasigade JP, Hollandt F, and Wirth T
- Subjects
- Anti-Bacterial Agents pharmacology, Bacillus cereus classification, Bacillus cereus drug effects, Bacillus cereus pathogenicity, Cell Division, Cell Wall, DNA Replication, Drug Resistance, Bacterial, Phylogeny, Recombination, Genetic, Virulence Factors, Bacillus cereus genetics, Evolution, Molecular, Genes, Bacterial, Genome, Bacterial, Genomics, Gram-Positive Bacterial Infections microbiology, Selection, Genetic
- Abstract
In this comparative genomics study our aim was to unravel genes under positive selection in the core genome of the Bacillus cereus group. Indeed, the members of this group share close genetic relationships but display a rather large phenotypic and ecological diversity, providing a unique opportunity for studying how genomic changes reflect ecological adaptation during the divergence of a bacterial group. For this purpose, we screened ten completely sequenced genomes of four pathogenic Bacillus species, finding that 254 out of 3093 genes have codon sites with d
N /dS (ω) values above one. These results remained unchanged after having disentangled the confounding effects of recombination and selection signature in a Bayesian framework. The presumably adaptive nucleotide polymorphisms are distributed over a wide range of biological functions, such as antibiotic resistance, DNA repair, nutrient uptake, metabolism, cell wall assembly and spore structure. Our results indicate that adaptation to animal hosts, whether as pathogens, saprophytes or symbionts, is the major driving force in the evolution of the Bacillus cereus group. Future work should seek to understand the evolutionary dynamics of both core and accessory genes in an integrative framework to ultimately unravel the key networks involved in host adaptation., (Copyright © 2018 Elsevier B.V. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
32. Compensatory evolution drives multidrug-resistant tuberculosis in Central Asia.
- Author
-
Merker M, Barbier M, Cox H, Rasigade JP, Feuerriegel S, Kohl TA, Diel R, Borrell S, Gagneux S, Nikolayevskyy V, Andres S, Nübel U, Supply P, Wirth T, and Niemann S
- Subjects
- Antitubercular Agents pharmacology, Drug Resistance, Multiple, Bacterial, Humans, Molecular Epidemiology, Mutation, Mycobacterium tuberculosis isolation & purification, Selection, Genetic, Uzbekistan epidemiology, Whole Genome Sequencing, Disease Transmission, Infectious, Evolution, Molecular, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis genetics, Tuberculosis, Multidrug-Resistant epidemiology, Tuberculosis, Multidrug-Resistant microbiology
- Abstract
Bacterial factors favoring the unprecedented multidrug-resistant tuberculosis (MDR-TB) epidemic in the former Soviet Union remain unclear. We utilized whole genome sequencing and Bayesian statistics to analyze the evolutionary history, temporal emergence of resistance and transmission networks of MDR Mycobacterium tuberculosis complex isolates from Karakalpakstan, Uzbekistan (2001-2006). One clade (termed Central Asian outbreak, CAO) dating back to 1974 (95% HPD 1969-1982) subsequently acquired resistance mediating mutations to eight anti-TB drugs. Introduction of standardized WHO-endorsed directly observed treatment, short-course in Karakalpakstan in 1998 likely selected for CAO-strains, comprising 75% of sampled MDR-TB isolates in 2005/2006. CAO-isolates were also identified in a published cohort from Russia (2008-2010). Similarly, the presence of mutations supposed to compensate bacterial fitness deficits was associated with transmission success and higher drug resistance rates. The genetic make-up of these MDR-strains threatens the success of both empirical and standardized MDR-TB therapies, including the newly WHO-endorsed short MDR-TB regimen in Uzbekistan., Competing Interests: MM, MB, HC, JR, SF, TK, RD, SB, SG, VN, SA, UN, PS, TW, SN No competing interests declared, (© 2018, Merker et al.)
- Published
- 2018
- Full Text
- View/download PDF
33. MAVS deficiency induces gut dysbiotic microbiota conferring a proallergic phenotype.
- Author
-
Plantamura E, Dzutsev A, Chamaillard M, Djebali S, Moudombi L, Boucinha L, Grau M, Macari C, Bauché D, Dumitrescu O, Rasigade JP, Lippens S, Plateroti M, Kress E, Cesaro A, Bondu C, Rothermel U, Heikenwälder M, Lina G, Bentaher-Belaaouaj A, Marie JC, Caux C, Trinchieri G, Marvel J, and Michallet MC
- Subjects
- Animals, Disease Models, Animal, Female, Homeodomain Proteins genetics, Homeodomain Proteins metabolism, Hypersensitivity metabolism, Hypersensitivity pathology, Intestines microbiology, Intestines pathology, Mice, Mice, Inbred C57BL, Mice, Knockout, Phenotype, Signal Transduction, Skin Diseases, Bacterial metabolism, Skin Diseases, Bacterial pathology, Adaptor Proteins, Signal Transducing physiology, Dysbiosis complications, Gastrointestinal Microbiome immunology, Hypersensitivity etiology, Intestines immunology, Skin Diseases, Bacterial etiology
- Abstract
Prominent changes in the gut microbiota (referred to as "dysbiosis") play a key role in the development of allergic disorders, but the underlying mechanisms remain unknown. Study of the delayed-type hypersensitivity (DTH) response in mice contributed to our knowledge of the pathophysiology of human allergic contact dermatitis. Here we report a negative regulatory role of the RIG-I-like receptor adaptor mitochondrial antiviral signaling (MAVS) on DTH by modulating gut bacterial ecology. Cohousing and fecal transplantation experiments revealed that the dysbiotic microbiota of Mavs
-/- mice conferred a proallergic phenotype that is communicable to wild-type mice. DTH sensitization coincided with increased intestinal permeability and bacterial translocation within lymphoid organs that enhanced DTH severity. Collectively, we unveiled an unexpected impact of RIG-I-like signaling on the gut microbiota with consequences on allergic skin disease outcome. Primarily, these data indicate that manipulating the gut microbiota may help in the development of therapeutic strategies for the treatment of human allergic skin pathologies., Competing Interests: The authors declare no conflict of interest.- Published
- 2018
- Full Text
- View/download PDF
34. New host shift from human to cows within Staphylococcus aureus involved in bovine mastitis and nasal carriage of animal's caretakers.
- Author
-
Akkou M, Bouchiat C, Antri K, Bes M, Tristan A, Dauwalder O, Martins-Simoes P, Rasigade JP, Etienne J, Vandenesch F, Ramdani-Bouguessa N, and Laurent F
- Subjects
- Animals, Bacterial Typing Techniques veterinary, Carrier State, Cattle, Female, Geography, Host Specificity, Humans, Mastitis, Bovine microbiology, Methicillin Resistance, Methicillin-Resistant Staphylococcus aureus genetics, Methicillin-Resistant Staphylococcus aureus physiology, Multilocus Sequence Typing veterinary, Nose microbiology, Oligonucleotide Array Sequence Analysis veterinary, Prevalence, Staphylococcal Infections epidemiology, Staphylococcal Infections microbiology, Staphylococcus aureus genetics, Virulence Factors genetics, Mastitis, Bovine epidemiology, Staphylococcal Infections veterinary, Staphylococcus aureus physiology
- Abstract
Staphylococcus aureus is a commensal and pathogen of both humans and bovines. While the epidemiology of both groups has been extensively studied individually, little is known about the potential zoonotic transfer from animal strains to human being and vice versa. To determine the S. aureus prevalence of bovine mastitis in Algeria and the zoonotic transfer of strains to human beings, mastitis milk samples were collected, and professionals in a close contact with bovines were nasal swabbed. S. aureus isolates were all characterized by methicillin resistance and spa-typing. DNA microarrays analysis was performed on a subset of strains in order to detect other virulence factors, including toxins, and to assign the isolates to theirs MLST clonal complexes. Overall, 116/222 (52.3%) cows suffered from mastitis, whose 38.8% (45/116) infected with S. aureus. Human nasal carriage was of 38% (49/129), with only 4 MRSA carriers (3.1%). A higher diversity of spa-types was observed in human (35/50) than in bovine (18/67) isolates, with a predominance of clonal complexes CC97 and CC22 in bovines. The typical animal clone CC97 was occasionally detected in human beings. Conversely, the CC22 S. aureus clone largely switched from humans to bovines. Our study highlights the potential dynamics of animal and human S. aureus strains in the farm environment in Algeria, which may represent a health threat in both populations., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
35. High levels of Staphylococcus aureus and MRSA carriage in healthy population of Algiers revealed by additional enrichment and multisite screening.
- Author
-
Antri K, Akkou M, Bouchiat C, Bes M, Martins-Simoes P, Dauwalder O, Tristan A, Meugnier H, Rasigade JP, Etienne J, Vandenesch F, Laurent F, and Ramdani-Bouguessa N
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Algeria epidemiology, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents therapeutic use, Child, Child, Preschool, Female, Genes, Bacterial, Humans, Infant, Infant, Newborn, Male, Methicillin Resistance, Middle Aged, Nasal Cavity microbiology, Pharynx microbiology, Phylogeny, Public Health Surveillance, Young Adult, Carrier State epidemiology, Carrier State microbiology, Methicillin-Resistant Staphylococcus aureus classification, Methicillin-Resistant Staphylococcus aureus drug effects, Methicillin-Resistant Staphylococcus aureus genetics, Methicillin-Resistant Staphylococcus aureus isolation & purification, Staphylococcus aureus classification, Staphylococcus aureus drug effects, Staphylococcus aureus genetics, Staphylococcus aureus isolation & purification
- Abstract
The purpose of the research is to characterize Staphylococcus aureus colonization in healthy population of Algiers, to assess the impact on diagnostic performance of systematic additional broth enrichment, and to ascertain the additional benefits of multiple site screening. In order to more accurately determine the prevalence of S. aureus colonization, the swab specimens from multiple screening sites were incubated in brain-heart broth before agar plating. From 2009 to 2011, 1176 samples were collected from 459 participants (201 adults and 258 children). The additional enrichment detection step significantly increased S. aureus detection rates (p < 0.0001). S. aureus nasal detection was positive in 37.8% of adults, and the addition of throat samplings significantly increased the S. aureus detection rate up to 54.7% (p < 0.001). S. aureus nasal detection was positive in 37.6% of children. The addition of throat samplings in children significantly increased the S. aureus detection rate up to 53.1% (p < 0.001) and that of anal samplings up to 59.7%. The overall prevalence of methicillin-resistant S. aureus was 5.2% (3% of adults and 7% of children). spa typing of all isolates revealed a diverse but strongly clonal S. aureus population structure. This approach involving multiple anatomical sampling sites and an additional enrichment of the swabs before conventional culture significantly increases the detection rate of S. aureus carriers and may prove valuable to improve global S. aureus infection prevention.
- Published
- 2018
- Full Text
- View/download PDF
36. Complex ecological interactions of Staphylococcus aureus in tampons during menstruation.
- Author
-
Jacquemond I, Muggeo A, Lamblin G, Tristan A, Gillet Y, Bolze PA, Bes M, Gustave CA, Rasigade JP, Golfier F, Ferry T, Dubost A, Abrouk D, Barreto S, Prigent-Combaret C, Thioulouse J, Lina G, and Muller D
- Subjects
- Adult, DNA Barcoding, Taxonomic, Female, Humans, Menstrual Hygiene Products microbiology, RNA, Ribosomal, 16S, Staphylococcus aureus, Young Adult, Bacteria isolation & purification, Menstruation, Microbiota, Shock, Septic microbiology, Staphylococcal Infections microbiology, Vagina microbiology
- Abstract
Menstrual toxic shock syndrome (mTSS) is a severe disease that occurs in healthy women vaginally colonized by Staphylococcus aureus producing toxic shock toxin 1 and who use tampons. The aim of the present study was to determine the impact of the composition of vaginal microbial communities on tampon colonisation by S. aureus during menses. We analysed the microbiota in menstrual fluids extracted from tampons from 108 healthy women and 7 mTSS cases. Using culture, S. aureus was detected in menstrual fluids of 40% of healthy volunteers and 100% of mTSS patients. Between class analysis of culturomic and 16S rRNA gene metabarcoding data indicated that the composition of the tampons' microbiota differs according to the presence or absence of S. aureus and identify discriminating genera. However, the bacterial communities of tampon fluid positive for S. aureus did not cluster together. No difference in tampon microbiome richness, diversity, and ecological distance was observed between tampon vaginal fluids with or without S. aureus, and between healthy donors carrying S. aureus and mTSS patients. Our results show that the vagina is a major niche of. S. aureus in tampon users and the composition of the tampon microbiota control its virulence though more complex interactions than simple inhibition by lactic acid-producing bacterial species.
- Published
- 2018
- Full Text
- View/download PDF
37. Staphylococcus aureus CC30 Lineage and Absence of sed , j , r -Harboring Plasmid Predict Embolism in Infective Endocarditis.
- Author
-
Rasigade JP, Leclère A, Alla F, Tessier A, Bes M, Lechiche C, Vernet-Garnier V, Laouénan C, Vandenesch F, and Leport C
- Subjects
- Bacterial Proteins genetics, DNA, Bacterial genetics, Embolism complications, Embolism microbiology, Endocarditis complications, Endocarditis microbiology, Endocarditis, Bacterial complications, Endocarditis, Bacterial microbiology, Female, France, Genes, Bacterial genetics, Genotype, Humans, Logistic Models, Male, Methicillin-Resistant Staphylococcus aureus genetics, Middle Aged, Multivariate Analysis, Penicillin-Binding Proteins genetics, Prospective Studies, Risk Factors, Staphylococcal Infections complications, Staphylococcal Infections microbiology, Staphylococcus aureus classification, Staphylococcus aureus pathogenicity, Superantigens, Virulence Factors genetics, Embolism diagnosis, Endocarditis diagnosis, Endocarditis, Bacterial diagnosis, Enterotoxins genetics, Plasmids genetics, Staphylococcal Infections diagnosis, Staphylococcus aureus genetics, Staphylococcus aureus isolation & purification
- Abstract
Staphylococcus aureus induces severe infective endocarditis (IE) where embolic complications are a major cause of death. Risk factors for embolism have been reported such as a younger age or larger IE vegetations, while methicillin resistance conferred by the mecA gene appeared as a protective factor. It is unclear, however, whether embolism is influenced by other S. aureus characteristics such as clonal complex (CC) or virulence pattern. We examined clinical and microbiological predictors of embolism in a prospective multicentric cohort of 98 French patients with monomicrobial S. aureus IE. The genomic contents of causative isolates were characterized using DNA array. To preserve statistical power, genotypic predictors were restricted to CC, secreted virulence factors and virulence regulators. Multivariate regularized logistic regression identified three independent predictors of embolism. Patients at higher risk were younger than the cohort median age of 62.5 y (adjusted odds ratio [OR] 0.14; 95% confidence interval [CI] 0.05-0.36). S. aureus characteristics predicting embolism were a CC30 genetic background (adjusted OR 9.734; 95% CI 1.53-192.8) and the absence of pIB485-like plasmid-borne enterotoxin-encoding genes sed, sej , and ser ( sedjr ; adjusted OR 0.07; 95% CI 0.004-0.457). CC30 S. aureus has been repeatedly reported to exhibit enhanced fitness in bloodstream infections, which might impact its ability to cause embolism. sedjr -encoded enterotoxins, whose superantigenic activity is unlikely to protect against embolism, possibly acted as a proxy to others genes of the pIB485-like plasmid found in genetically unrelated isolates from mostly embolism-free patients. mecA did not independently predict embolism but was strongly associated with sedjr . This mecA - sedjr association might have driven previous reports of a negative association of mecA and embolism. Collectively, our results suggest that the influence of S. aureus genotypic features on the risk of embolism may be stronger than previously suspected and independent of clinical risk factors.
- Published
- 2018
- Full Text
- View/download PDF
38. Changing patterns of human migrations shaped the global population structure of Mycobacterium tuberculosis in France.
- Author
-
Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, Pérouse de Montclos M, Genestet C, Flandrois JP, Ader F, Supply P, Lina G, Wirth T, and Rasigade JP
- Subjects
- Africa, Northern epidemiology, Cross-Sectional Studies, DNA, Bacterial genetics, DNA, Bacterial isolation & purification, Datasets as Topic, France epidemiology, Haplotypes, Humans, Incidence, Minisatellite Repeats genetics, Mycobacterium tuberculosis isolation & purification, Retrospective Studies, Tuberculosis epidemiology, Tuberculosis transmission, Human Migration statistics & numerical data, Mycobacterium tuberculosis genetics, Phylogeography statistics & numerical data, Tuberculosis microbiology
- Abstract
Mycobacterium tuberculosis (Mtb) exhibits a structured phylogeographic distribution worldwide linked with human migrations. We sought to infer how the interactions between distinct human populations shape the global population structure of Mtb on a regional scale. We applied the recently described timescaled haplotypic density (THD) technique on 638 minisatellite-based Mtb genotypes from French tuberculosis patients. THD with a long-term (200 y) timescale indicated that Mtb population in France had been mostly influenced by interactions with Eastern and Southern Europe and, to a lesser extent, Northern and Middle Africa, consistent with historical migrations favored by geographic proximity or commercial exchanges with former French colonies. Restricting the timescale to 20 y, THD identified a sustained influence of Northern Africa, but not Europe where tuberculosis incidence decreased sharply. Evolving interactions between human populations, thus, measurably influence the local population structure of Mtb. Relevant information on such interactions can be inferred using THD from Mtb genotypes.
- Published
- 2018
- Full Text
- View/download PDF
39. Chromogenic detection procedure for the multidrug-resistant, neonatal sepsis-associated clone Staphylococcus capitis NRCS-A.
- Author
-
Butin M, Dumont Y, Rasigade JP, Martins Simoes P, Hoden L, Picaud JC, and Laurent F
- Subjects
- Chromogenic Compounds metabolism, Feces microbiology, Female, Humans, Infant, Newborn, Intensive Care, Neonatal, Neonatal Sepsis diagnosis, Pregnancy, Skin microbiology, Staphylococcal Infections diagnosis, Staphylococcus capitis metabolism, Vagina microbiology, Bacteriological Techniques methods, Chromogenic Compounds analysis, Neonatal Sepsis microbiology, Staphylococcal Infections microbiology, Staphylococcus capitis isolation & purification
- Abstract
The multiresistant Staphylococcus capitis clone NRCS-A is a major pathogen in neonates worldwide. We show that NRCS-A grows as mauve colonies with a cream-color halo after a 5-day incubation on MRSA Brilliance 2 agar (Oxoid®). This innovative protocol will ease the screening of clinical and environmental niches of this clone., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
40. Catching the evader: Can monoclonal antibodies interfere with Staphylococcus aureus immune escape?
- Author
-
Rasigade JP
- Subjects
- Humans, Protein Binding, Staphylococcal Infections, Antibodies, Monoclonal, Staphylococcus aureus immunology
- Published
- 2018
- Full Text
- View/download PDF
41. Vancomycin treatment is a risk factor for vancomycin-nonsusceptible Staphylococcus capitis sepsis in preterm neonates.
- Author
-
Butin M, Rasigade JP, Subtil F, Martins-Simões P, Pralong C, Freydière AM, Vandenesch F, Tigaud S, Picaud JC, and Laurent F
- Subjects
- Anti-Bacterial Agents adverse effects, Anti-Bacterial Agents pharmacology, Female, Humans, Infant, Newborn, Male, Risk Factors, Vancomycin adverse effects, Vancomycin pharmacology, Anti-Bacterial Agents therapeutic use, Drug Resistance, Bacterial drug effects, Premature Birth epidemiology, Staphylococcal Infections drug therapy, Staphylococcal Infections epidemiology, Staphylococcal Infections microbiology, Staphylococcus capitis drug effects, Vancomycin therapeutic use
- Abstract
Objectives: Multidrug-resistant, vancomycin-nonsusceptible Staphylococcus capitis is an emerging cause worldwide of late-onset sepsis (LOS) in preterm neonates. The pathophysiology and risk factors for S. capitis-related LOS are poorly understood, but we hypothesized that S. capitis LOS follows translocation from the gut microbiota rather than catheter invasion. The objective of this study was to investigate the risk factors of S. capitis LOS and gut colonization., Methods: We conducted a prospective single-centre cohort study of patients hospitalized in a tertiary-care unit (Lyon, France) from June 2011 to January 2012. S. capitis gut colonization was determined weekly from stool cultures. The determinants of gut colonization and LOS were established by multivariate Cox proportional hazards models., Results: Eighty-three (36.2%) of 229 patients had S. capitis-positive stool culture, and 28 (12.2%) developed S. capitis LOS during hospitalization. Independent risk factors for S. capitis LOS included prior administration of vancomycin independent of a previous LOS episode (hazard ratio 6.44, 95% confidence interval 2.15-19.3, p 0.001) and low birth weight (hazard ratio 0.72 per 100 g increase, 95% confidence interval 0.55-0.95, p 0.02). The prior administration of vancomycin was also an independent risk factor for S. capitis colonization (hazard ratio 3.45, 95% confidence interval 2.07-5.76, p <0.001), particularly in the first week of life and in noncolonized neonates., Conclusions: Neonates treated with vancomycin are at a higher risk of LOS caused by vancomycin-nonsusceptible S. capitis. The use of vancomycin in neonates must urgently be optimized to limit the selection of vancomycin-nonsusceptible strains, for which alternative antibiotics are lacking., (Copyright © 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
42. Strain-specific estimation of epidemic success provides insights into the transmission dynamics of tuberculosis.
- Author
-
Rasigade JP, Barbier M, Dumitrescu O, Pichat C, Carret G, Ronnaux-Baron AS, Blasquez G, Godin-Benhaim C, Boisset S, Carricajo A, Jacomo V, Fredenucci I, Pérouse de Montclos M, Flandrois JP, Ader F, Supply P, Lina G, and Wirth T
- Subjects
- Adult, Aged, Female, Genetic Variation, Genotype, Haplotypes, Humans, Male, Middle Aged, Minisatellite Repeats genetics, Mycobacterium tuberculosis isolation & purification, Risk Factors, Sputum microbiology, Tuberculosis epidemiology, Tuberculosis microbiology, Tuberculosis transmission, Mycobacterium tuberculosis genetics, Tuberculosis pathology
- Abstract
The transmission dynamics of tuberculosis involves complex interactions of socio-economic and, possibly, microbiological factors. We describe an analytical framework to infer factors of epidemic success based on the joint analysis of epidemiological, clinical and pathogen genetic data. We derive isolate-specific, genetic distance-based estimates of epidemic success, and we represent success-related time-dependent concepts, namely epidemicity and endemicity, by restricting analysis to specific time scales. The method is applied to analyze a surveillance-based cohort of 1,641 tuberculosis patients with minisatellite-based isolate genotypes. Known predictors of isolate endemicity (older age, native status) and epidemicity (younger age, sputum smear positivity) were identified with high confidence (P < 0.001). Long-term epidemic success also correlated with the ability of Euro-American and Beijing MTBC lineages to cause active pulmonary infection, independent of patient age and country of origin. Our results demonstrate how important insights into the transmission dynamics of tuberculosis can be gained from active surveillance data.
- Published
- 2017
- Full Text
- View/download PDF
43. Worldwide Endemicity of a Multidrug-Resistant Staphylococcus capitis Clone Involved in Neonatal Sepsis.
- Author
-
Butin M, Martins-Simões P, Rasigade JP, Picaud JC, and Laurent F
- Subjects
- Endemic Diseases, Global Health, Humans, Infant, Newborn, Neonatal Sepsis epidemiology, Anti-Bacterial Agents pharmacology, Drug Resistance, Multiple, Bacterial, Neonatal Sepsis microbiology, Staphylococcal Infections epidemiology, Staphylococcal Infections microbiology, Staphylococcus capitis drug effects
- Abstract
A multidrug-resistant Staphylococcus capitis clone, NRCS-A, has been isolated from neonatal intensive care units in 17 countries throughout the world. S. capitis NRCS-A prevalence is high in some neonatal intensive care units in France. These data highlight the worldwide endemicity and epidemiologic relevance of this multidrug-resistant, coagulase-negative staphylococci clone.
- Published
- 2017
- Full Text
- View/download PDF
44. Single-Molecule Sequencing (PacBio) of the Staphylococcus capitis NRCS-A Clone Reveals the Basis of Multidrug Resistance and Adaptation to the Neonatal Intensive Care Unit Environment.
- Author
-
Simões PM, Lemriss H, Dumont Y, Lemriss S, Rasigade JP, Assant-Trouillet S, Ibrahimi A, El Kabbaj S, Butin M, and Laurent F
- Abstract
The multi-resistant Staphylococcus capitis clone NRCS-A has recently been described as a major pathogen causing nosocomial, late-onset sepsis (LOS) in preterm neonates worldwide. NRCS-A representatives exhibit an atypical antibiotic resistance profile. Here, the complete closed genome (chromosomal and plasmid sequences) of NRCS-A prototype strain CR01 and the draft genomes of three other clinical NRCS-A strains from Australia, Belgium and the United Kingdom are annotated and compared to available non-NRCS-A S. capitis genomes. Our goal was to delineate the uniqueness of the NRCS-A clone with respect to antibiotic resistance, virulence factors and mobile genetic elements. We identified 6 antimicrobial resistance genes, all carried by mobile genetic elements. Previously described virulence genes present in the NRCS-A genomes are shared with the six non-NRCS-A S. capitis genomes. Overall, 63 genes are specific to the NRCS-A lineage, including 28 genes located in the methicillin-resistance cassette SCC mec . Among the 35 remaining genes, 25 are of unknown function, and 9 correspond to an additional type I restriction modification system ( n = 3), a cytosine methylation operon ( n = 2), and a cluster of genes related to the biosynthesis of teichoic acids ( n = 4). Interestingly, a tenth gene corresponds to a resistance determinant for nisin ( nsr gene), a bacteriocin secreted by potential NRCS-A strain niche competitors in the gut microbiota. The genomic characteristics presented here emphasize the contribution of mobile genetic elements to the emergence of multidrug resistance in the S. capitis NRCS-A clone. No NRCS-A-specific known virulence determinant was detected, which does not support a role for virulence as a driving force of NRCS-A emergence in NICUs worldwide. However, the presence of a nisin resistance determinant on the NRCS-A chromosome, but not in other S. capitis strains and most coagulase-negative representatives, might confer a competitive advantage to NRCS-A strains during the early steps of gut colonization in neonates. This suggests that the striking adaptation of NRCS-A to the NICU environment might be related to its specific antimicrobial resistance and also to a possible enhanced ability to challenge competing bacteria in its ecological niche.
- Published
- 2016
- Full Text
- View/download PDF
45. Disk Diffusion Testing for Detection of Methicillin-Resistant Staphylococci: Does Moxalactam Improve upon Cefoxitin?
- Author
-
Bonjean M, Hodille E, Dumitrescu O, Dupieux C, Nkoud Mongo C, Allam C, Beghin M, Paris M, Borrel O, Chardon H, Laurent F, Rasigade JP, and Lina G
- Subjects
- Bacterial Proteins genetics, Humans, Methicillin-Resistant Staphylococcus aureus genetics, Penicillin-Binding Proteins genetics, Staphylococcus lugdunensis drug effects, Staphylococcus lugdunensis genetics, Staphylococcus lugdunensis isolation & purification, Staphylococcus saprophyticus drug effects, Staphylococcus saprophyticus genetics, Staphylococcus saprophyticus isolation & purification, Anti-Bacterial Agents pharmacology, Cefoxitin pharmacology, Disk Diffusion Antimicrobial Tests methods, Methicillin-Resistant Staphylococcus aureus drug effects, Methicillin-Resistant Staphylococcus aureus isolation & purification, Moxalactam pharmacology
- Abstract
Disk diffusion testing is widely used to detect methicillin resistance in staphylococci, and cefoxitin is currently considered the best marker for mecA-mediated methicillin resistance. In low-inoculum diffusion testing (colony suspension at 10
6 CFU/ml), the addition of moxalactam in combination with cefoxitin has been reported to improve on cefoxitin alone for the detection of methicillin-heteroresistant staphylococci. However, moxalactam is absent from EUCAST and CLSI guidelines, which use high-inoculum diffusion testing (colony suspension at 108 CFU/ml), calling into question the potential interest of including moxalactam in their recommendations. The inhibition zone diameters of cefoxitin and moxalactam, alone and in combination, were evaluated for concordance with mecA and mecC positivity in a large collection of clinical Staphylococcus isolates (611 Staphylococcus aureus, Staphylococcus lugdunensis, and Staphylococcus saprophyticus isolates and 307 coagulase-negative staphylococci other than S. lugdunensis and S. saprophyticus isolates, of which 22% and 53% were mecA-positive, respectively) and in 25 mecC-positive S. aureus isolates using high-inoculum diffusion testing. Receiver operating characteristic, sensitivity, and specificity analyses indicated that the detection of mecA- and mecC-positive and negative isolates did not improve with moxalactam, either alone or in combination with cefoxitin, compared to cefoxitin alone. These findings were similar in both the S. aureus/S. lugdunensis/S. saprophyticus group and in the coagulase-negative staphylococci group. Our results do not support the use of moxalactam as an additional marker of methicillin resistance when testing with high-inoculum disk diffusion., (Copyright © 2016, American Society for Microbiology. All Rights Reserved.)- Published
- 2016
- Full Text
- View/download PDF
46. A Prophage in Diabetic Foot Ulcer-Colonizing Staphylococcus aureus Impairs Invasiveness by Limiting Intracellular Growth.
- Author
-
Rasigade JP, Dunyach-Rémy C, Sapin A, Messad N, Trouillet-Assant S, Dupieux C, Lavigne JP, and Laurent F
- Subjects
- Diabetic Foot complications, Follow-Up Studies, France, Humans, Longitudinal Studies, Prospective Studies, Virulence, Diabetic Foot microbiology, Osteoblasts microbiology, Prophages growth & development, Staphylococcal Infections microbiology, Staphylococcus aureus growth & development, Staphylococcus aureus virology
- Abstract
The mechanisms that drive the transition from commensality to invasiveness in Staphylococcus aureus are poorly understood. We recently reported that >50% of S. aureus isolates from uninfected diabetic foot ulcers in French patients harbor a prophage, ROSA-like, that is absent from invasive isolates from diabetic foot infections, including osteomyelitis. Here we show that the ROSA-like insertion abolishes the ability of S. aureus to replicate within osteoblasts, the bone-forming cells, greatly reducing damage to infected cells. These results unravel an important mechanism by which particular S. aureus strains are maintained in a commensal state in diabetic foot ulcers., (© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.)
- Published
- 2016
- Full Text
- View/download PDF
47. Adaptive processes of Staphylococcus aureus isolates during the progression from acute to chronic bone and joint infections in patients.
- Author
-
Trouillet-Assant S, Lelièvre L, Martins-Simões P, Gonzaga L, Tasse J, Valour F, Rasigade JP, Vandenesch F, Muniz Guedes RL, Ribeiro de Vasconcelos AT, Caillon J, Lustig S, Ferry T, Jacqueline C, Loss de Morais G, and Laurent F
- Subjects
- Adaptation, Physiological, Adult, Aged, 80 and over, Amino Acid Sequence, Cells, Cultured, Chronic Disease, Disease Progression, Female, Hemolysin Proteins metabolism, Host-Pathogen Interactions, Humans, Male, Osteoblasts immunology, Osteoblasts microbiology, Arthritis, Infectious microbiology, Biofilms, Staphylococcal Infections microbiology, Staphylococcus aureus physiology
- Abstract
Staphylococcus aureus bone and joint infection (BJI) is associated with significant rates of chronicity and relapse. In this study, we investigated how S. aureus is able to adapt to the human environment by comparing isolates from single patients with persisting or relapsing BJIs that were recovered during the initial and recurrent BJI episodes. In vitro and in vivo assays and whole-genome sequencing analyses revealed that the recurrent isolates induced a reduced inflammatory response, formed more biofilms, persisted longer in the intracellular compartments of host bone cells, were less cytotoxic and induced less mortality in a mouse infection model compared with the initial isolates despite the lack of significant changes at the genomic level. These findings suggest that S. aureus BJI chronicization is associated with an in vivo bacterial phenotypical adaptation that leads to decreased virulence and host immune escape, which is linked to increased intraosteoblastic persistence and biofilm formation., (© 2016 John Wiley & Sons Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
48. IVIG-mediated protection against necrotizing pneumonia caused by MRSA.
- Author
-
Diep BA, Le VT, Badiou C, Le HN, Pinheiro MG, Duong AH, Wang X, Dip EC, Aguiar-Alves F, Basuino L, Marbach H, Mai TT, Sarda MN, Kajikawa O, Matute-Bello G, Tkaczyk C, Rasigade JP, Sellman BR, Chambers HF, and Lina G
- Subjects
- Acute Lung Injury drug therapy, Acute Lung Injury microbiology, Acute Lung Injury pathology, Animals, Antibiotic Prophylaxis, Antibodies, Neutralizing immunology, Bacterial Toxins immunology, Disease Models, Animal, Exotoxins immunology, Hemolysin Proteins immunology, Humans, Leukocidins immunology, Linezolid pharmacology, Linezolid therapeutic use, Methicillin-Resistant Staphylococcus aureus immunology, Rabbits, Vancomycin pharmacology, Vancomycin therapeutic use, Immunoglobulins, Intravenous therapeutic use, Methicillin-Resistant Staphylococcus aureus physiology, Pneumonia, Necrotizing drug therapy, Pneumonia, Necrotizing microbiology
- Abstract
New therapeutic approaches are urgently needed to improve survival outcomes for patients with necrotizing pneumonia caused by Staphylococcus aureus One such approach is adjunctive treatment with intravenous immunoglobulin (IVIG), but clinical practice guidelines offer conflicting recommendations. In a preclinical rabbit model, prophylaxis with IVIG conferred protection against necrotizing pneumonia caused by five different epidemic strains of community-associated methicillin-resistant S. aureus (MRSA) as well as a widespread strain of hospital-associated MRSA. Treatment with IVIG, either alone or in combination with vancomycin or linezolid, improved survival outcomes in this rabbit model. Two specific IVIG antibodies that neutralized the toxic effects of α-hemolysin (Hla) and Panton-Valentine leukocidin (PVL) conferred protection against necrotizing pneumonia in the rabbit model. This mechanism of action of IVIG was uncovered by analyzing loss-of-function mutant bacterial strains containing deletions in 17 genes encoding staphylococcal exotoxins, which revealed only Hla and PVL as having an impact on necrotizing pneumonia. These results demonstrate the potential clinical utility of IVIG in the treatment of severe pneumonia induced by S. aureus., (Copyright © 2016, American Association for the Advancement of Science.)
- Published
- 2016
- Full Text
- View/download PDF
49. Late-onset sepsis due to Staphylococcus capitis 'neonatalis' in low-birthweight infants: a new entity?
- Author
-
Ben Said M, Hays S, Bonfils M, Jourdes E, Rasigade JP, Laurent F, and Picaud JC
- Subjects
- Female, Humans, Infant, Infant, Newborn, Late Onset Disorders microbiology, Late Onset Disorders pathology, Male, Neonatal Sepsis microbiology, Neonatal Sepsis pathology, Prospective Studies, Staphylococcal Infections microbiology, Staphylococcal Infections pathology, Staphylococcus classification, Infant, Low Birth Weight, Late Onset Disorders epidemiology, Neonatal Sepsis epidemiology, Staphylococcal Infections epidemiology, Staphylococcus isolation & purification
- Abstract
During hospitalization, sepsis occurs in one of every five very-low-birthweight infants. The emergence of Staphylococcus capitis (SC)-related sepsis in preterm infants was observed recently. This study aimed to evaluate the clinical severity of SC-related sepsis in preterm infants. Of the 105 infants who presented with sepsis related to coagulase-negative staphylococci, 74 were SC. Severe morbidity was more common in the SC group (55.4%) than in the non-SC coagulase-negative staphylococci group (32.0%) (P=0.03). Multi-variate analysis identified SC-related sepsis as an independent risk factor for severe morbidity., (Copyright © 2016. Published by Elsevier Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
50. Pathophysiological Mechanisms of Staphylococcus Non-aureus Bone and Joint Infection: Interspecies Homogeneity and Specific Behavior of S. pseudintermedius.
- Author
-
Maali Y, Martins-Simões P, Valour F, Bouvard D, Rasigade JP, Bes M, Haenni M, Ferry T, Laurent F, and Trouillet-Assant S
- Abstract
Implicated in more than 60% of bone and joint infections (BJIs), Staphylococci have a particular tropism for osteoarticular tissue and lead to difficult-to-treat clinical infections. To date, Staphylococcus aureus internalization in non-professional phagocytic cells (NPPCs) is a well-explored virulence mechanism involved in BJI chronicity. Conversely, the pathophysiological pathways associated with Staphylococcus non-aureus (SNA) BJIs have scarcely been studied despite their high prevalence. In this study, 15 reference strains from 15 different SNA species were compared in terms of (i) adhesion to human fibronectin based on adhesion microplate assays and (ii) internalization ability, intracellular persistence and cytotoxicity based on an in vitro infection model using human osteoblasts. Compared to S. aureus, S. pseudintermedius was the only species that significantly adhered to human fibronectin. This species was also associated with high (even superior to S. aureus) internalization ability, intracellular persistence and cytotoxicity. These findings were confirmed using a panel of 17 different S. pseudintermedius isolates. Additionally, S. pseudintermedius internalization by osteoblasts was completely abolished in β1 integrin-deficient murine osteoblasts. These results suggest the involvement of β1 integrin in the invasion process, although this mechanism was previously restricted to S. aureus. In summary, our results suggest that internalization into NPPCs is not a classical pathophysiologic mechanism of SNA BJIs. S. pseudintermedius appears to be an exception, and its ability to invade and subsequently induce cytotoxicity in NPPCs could explain its severe and necrotic forms of infection, notably in dogs, which exhibit a high prevalence of S. pseudintermedius infection.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.